- $20.81bn
- $25.94bn
- $21.00bn
- 90
- 50
- 65
- 77
Annual income statement for CDW, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18,468 | 20,821 | 23,749 | 21,376 | 20,999 |
Cost of Revenue | |||||
Gross Profit | 3,210 | 3,569 | 4,687 | 4,652 | 4,602 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 17,288 | 19,366 | 22,014 | 19,695 | 19,347 |
Operating Profit | 1,179 | 1,455 | 1,735 | 1,681 | 1,651 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,002 | 1,298 | 1,488 | 1,450 | 1,435 |
Provision for Income Taxes | |||||
Net Income After Taxes | 789 | 989 | 1,115 | 1,104 | 1,078 |
Net Income Before Extraordinary Items | |||||
Net Income | 789 | 989 | 1,115 | 1,104 | 1,078 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 789 | 989 | 1,115 | 1,104 | 1,078 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.58 | 7.29 | 8.53 | 9.21 | 9.48 |
Dividends per Share |